除了守门之外:排水通过限制重绑定来远程破坏细胞质药物向相互作用的稳定性
bioRxiv : the preprint server for biology
|August 13, 2025
概括
细菌排泄不仅阻止药物进入,还破坏了细胞内药物与标的结合. 这种双重作用,包括守门和动力不稳定,显著增强了多种药物耐药性.
科学领域:
- 微生物学 微生物学
- 生物物理学的生物物理.
- 药理学 药理学是指药理学的学科.
背景情况:
- 细菌排泄是多药耐药性的关键,传统上被视为限制细胞内药物度的守门员.
- 它们在细胞内药物标相互作用中的确切作用仍然不完全理解.
研究的目的:
- 为了研究细菌流出的进入后机制.
- 阐明排泄如何影响细胞内药物标结合动态和亲和力.
主要方法:
- 使用Hoechst (HCT) 的活细胞光成像对*Escherichia coli*和*Pseudomonas aeruginosa*的排泄活动进行定量成像.
- 基于统计物理的建模,分析细胞内环境中的药物向相互作用.
- 模型预测的实验验证.
主要成果:
- 溢出不仅减少了细胞内药物进入,而且还动态地破坏了药物向相互作用的稳定.
- 在流量不足的细胞中,细胞内药物表现出增强的DNA结合稳定性和更高的亲和力.
- 溢出可以抑制药物与目标的重新结合,从而降低结合亲和力并增强耐药性.
结论:
- 细菌排泄通过破坏细胞内药物标相互作用而采用强大的后入内机制.
- 这种动力不稳定,与守门者一起,放大了多种药物耐药性.
- 这些发现揭示了排泄的新奇生物物理机制,扩大了对抗药性的理解.
更多相关视频
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
723
09:59Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
Published on: March 9, 2015
12.3K
相关概念视频
Factors Affecting Protein-Drug Binding: Drug Interactions
275
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
275
Drug Elimination by Renal Route: Tubular Reabsorption
3.9K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.9K
Drug-Receptor Bonds
3.3K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.3K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Drug Elimination by Renal Route: Tubular Secretion
2.5K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K
Drug Distribution: Plasma Protein Binding
6.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.7K
